Wave Life Sciences Ltd. (NASDAQ: WVE) kicked off on Friday, down -3.33% from the previous trading day, before settling in for the closing price of $6.00. Over the past 52 weeks, WVE has traded in a range of $3.15-$7.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 610.91%. While this was happening, its average annual earnings per share was recorded -87.04%. With a float of $96.36 million, this company’s outstanding shares have now reached $119.16 million.
The extent of productivity of a business whose workforce counts for 268 workers is very important to gauge.
Wave Life Sciences Ltd. (WVE) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd. is 21.20%, while institutional ownership is 74.64%. The most recent insider transaction that took place on Apr 03 ’24, was worth 96,421. In this transaction Chief Financial Officer of this company sold 15,630 shares at a rate of $6.17, taking the stock ownership to the 33,921 shares. Before that another transaction happened on Dec 11 ’23, when Company’s Director bought 1,000,000 for $5.00, making the entire transaction worth $5,000,000. This insider now owns 19,202,009 shares in total.
Wave Life Sciences Ltd. (WVE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.04% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd.’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 1.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.07 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
The latest stats from [Wave Life Sciences Ltd., WVE] show that its last 5-days average volume of 0.58 million was inferior to 0.89 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 56.98%. Additionally, its Average True Range was 0.40.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 55.16%, which indicates a significant increase from 39.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.64% in the past 14 days, which was lower than the 99.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.28, while its 200-day Moving Average is $5.00. Now, the first resistance to watch is $6.07. This is followed by the second major resistance level at $6.34. The third major resistance level sits at $6.54. If the price goes on to break the first support level at $5.60, it is likely to go to the next support level at $5.39. The third support level lies at $5.12 if the price breaches the second support level.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 709.22 million has total of 122,284K Shares Outstanding. Its annual sales at the moment are 113,310 K in contrast with the sum of -57,510 K annual income. Company’s last quarter sales were recorded 29,060 K and last quarter income was -16,260 K.
